Skip to content
← Full study record

NCT00561418 · MORE INFO

Limitations, agreements, and source contact

Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma · Source last updated 2015-07-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
craig.hofmeister@osumc.edu
organization
The Ohio State University Comprehensive Cancer Center
phone
614-293-9869
title
Craig Hofmeister, MD
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
craig.hofmeister@osumc.edu
organization
The Ohio State University Comprehensive Cancer Center
phone
614-293-9869
title
Craig Hofmeister, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice